DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Trofosfamide

Trofosfamide

  • Synthesis of 4-Hydroperoxy Derivatives of Ifosfamide and Trofosfamide by Direct Ozonation and Preliminary Antitumor Evaluation in V/Vo

    Synthesis of 4-Hydroperoxy Derivatives of Ifosfamide and Trofosfamide by Direct Ozonation and Preliminary Antitumor Evaluation in V/Vo

  • Combination Effects of Radiotherapy / Drug Treatments for Cancer Recommendation by the German Commission on Radiological Protection with Scientific Background

    Combination Effects of Radiotherapy / Drug Treatments for Cancer Recommendation by the German Commission on Radiological Protection with Scientific Background

  • Protocol of Clinical Study

    Protocol of Clinical Study

  • Intravenous Ascorbate and Oncologic Agents

    Intravenous Ascorbate and Oncologic Agents

  • Nephroblastoma High-Dose Chemotherapy with Autologous Stem Cell Rescue in Children with Nephroblastoma

    Nephroblastoma High-Dose Chemotherapy with Autologous Stem Cell Rescue in Children with Nephroblastoma

  • Cisplatin, Gemcitabine, and Treosulfan in Relapsed Stage IV Cutaneous Malignant Melanoma Patients

    Cisplatin, Gemcitabine, and Treosulfan in Relapsed Stage IV Cutaneous Malignant Melanoma Patients

  • Section B Changed Classes/Guidelines Final

    Section B Changed Classes/Guidelines Final

  • Multistage Delivery of Active Agents

    Multistage Delivery of Active Agents

  • Trofosfamide and Etoposide

    Trofosfamide and Etoposide

  • Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies

    Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies

  • Low-Dose Trofosfamide Plus Rituximab Is an Effective And

    Low-Dose Trofosfamide Plus Rituximab Is an Effective And

  • Anatomical Classification Guidelines V2021 EPHMRA ANATOMICAL CLASSIFICATION GUIDELINES 2021

    Anatomical Classification Guidelines V2021 EPHMRA ANATOMICAL CLASSIFICATION GUIDELINES 2021

  • Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

    Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

  • Ep 3067054 A1

    Ep 3067054 A1

  • Antigen Binding Protein and Its Use As Addressing Product for the Treatment of Cancer

    Antigen Binding Protein and Its Use As Addressing Product for the Treatment of Cancer

  • The Expression Profiles of ADME Genes in Human Cancers And

    The Expression Profiles of ADME Genes in Human Cancers And

  • Trofosfamide in the Treatment of Elderly Or Frail Patients with Diffuse Large B-Cell Lymphoma

    Trofosfamide in the Treatment of Elderly Or Frail Patients with Diffuse Large B-Cell Lymphoma

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

Top View
  • United States Patent ( 10 ) Patent No.: US 10,478,439 B2 Honigberg Et Al
  • ( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2020/0222392 A1
  • Cancer Control Coalition the Cost of CANCER in Texas
  • (12) United States Patent (1O) Patent No.: US 8,173,115 B2 Decuzzi Et Al
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • United States Patent $835 a 88: As: Inhibitor 1-((R)-3-(4-Amino-3-(4
  • Journal Pre-Proof
  • WO 2016/126552 Al 11 August 2016 (11.08.2016) P O P C T
  • Handling Cytostatic Drugs: Contents
  • Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory
  • From Old Alkylating Agents to New Minor Groove Binders
  • Section B Changed Classes/Guidelines Final
  • Gene Fragment Overexpression Screening Methodologies, and Uses Thereof
  • Cytostatics in the Aquatic Environment: Analysis, Occurrence, and Possibilities for Removal
  • POISONS LIST APPENDIX Amoebicides
  • 3.1 Basic Principles of Chemotherapy
  • 210311 Wild Guided Report.Indd
  • Justification


© 2024 Docslib.org    Feedback